Sergio Agosti
Research Subjects
Sergio Agosti has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Antonio Barsotti
3 shared publicationsClaudio Brunelli
3 shared publicationsGiovanni Bertero
3 shared publicationsSilvana Morelloni
3 shared publications- Gian Paolo Bezante
Cardiology Unit, Department of Internal Medicine, University of Genova, Viale Benedetto XV/6, Genoa, Italy
2 shared publications Laura Casalino
2 shared publications
Latest Publications
- Open Access
- 15 August 2017
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 11 (1) , 1-4
Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report
- 15 August 2017
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 11 (1) , 1-4
Open AccessSuccessful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report
- 1 November 2013
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 31 (11) , 1624.e1-1624.e2
Citalopram and levosulpiride: a dangerous drug combination for QT prolongation
- 1 November 2013
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 31 (11) , 1624.e1-1624.e2
Citalopram and levosulpiride: a dangerous drug combination for QT prolongation
- 1 January 2012
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 30 (1) , 248.e5-248.e8
A dangerous fruit juice
- 1 January 2012
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 30 (1) , 248.e5-248.e8
A dangerous fruit juice
- Open Access
- 1 January 2012
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 4 (4) , 289-91
Biventricular Pacemaker Implantation via the Femoral Vein
We report the case of biventricular pacemaker implantation via the femoral vein, in a patient with impossibility of using standard superior vein approach and acontraindication to epicardial lead placement
- 1 January 2012
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 4 (4) , 289-91
Open AccessBiventricular Pacemaker Implantation via the Femoral Vein
We report the case of biventricular pacemaker implantation via the femoral vein, in a patient with impossibility of using standard superior vein approach and acontraindication to epicardial lead placement
- 1 June 2010
- Vol. 11 (6) , 498-500
[Atrial myxoma presenting during pregnancy].
We report a case of left atrial myxoma presenting as acute respiratory failure following surgical intervention for voluntary interruption of pregnancy. After cardiac surgery T-wave changes were observed on the ECG, most likely due to coronary embolism.
- 1 June 2010
- Vol. 11 (6) , 498-500
[Atrial myxoma presenting during pregnancy].
We report a case of left atrial myxoma presenting as acute respiratory failure following surgical intervention for voluntary interruption of pregnancy. After cardiac surgery T-wave changes were observed on the ECG, most likely due to coronary embolism.
- 1 January 2010
- Vol. 161 (2) , 143-8
[Selection of candidates for cardiac resynchronisation therapy and prediction of their response.].
Cardiac resynchronization therapy is currently used in selected patients with end-stage heart failure. However, 30% of patients do not respond to CRT. The aim of our study was to find echocardiographic (TDI), electrocardiographic (QRS interval and electric distance between right and left catheter), clinical (6MW test) or autonomical (HRV) parameters able to predict responsiveness to CRT. 47 patients (mean age 74+/-10 years) with end-stage heart failure, symptomatic, with left ventricular (LV) ejection fraction less than 35% and QRS 120 ms, underwent CRT. At thirteen months follow up, all clinical and echocardiographic parameters significantly improves (EF p or = 5 units. There was a significant difference of LVED diameter (p<0.05) and HRV (p<0.05) between responders and non responders. Receiver-operating curve analysis showed that a positive response to CRT may be predicted in patients with LVED diameter <67 mm (with a sensitivity of 77% and a specificity of 88%). Our results confirm the clinical improvement obtained by CRT in end-stage heart failure patients as well as the limited value of QRS duration and intraventricular dyssynchrony as predictor of clinical recovery after CRT. While a most-advanced clinical stage of disease (HRV) without an advance left ventricular remodeling (LVED diameter) demonstrated to predict response to CRT, with sensitivity of 77% and specificity of 88%.
- 1 January 2010
- Vol. 161 (2) , 143-8
[Selection of candidates for cardiac resynchronisation therapy and prediction of their response.].
Cardiac resynchronization therapy is currently used in selected patients with end-stage heart failure. However, 30% of patients do not respond to CRT. The aim of our study was to find echocardiographic (TDI), electrocardiographic (QRS interval and electric distance between right and left catheter), clinical (6MW test) or autonomical (HRV) parameters able to predict responsiveness to CRT. 47 patients (mean age 74+/-10 years) with end-stage heart failure, symptomatic, with left ventricular (LV) ejection fraction less than 35% and QRS 120 ms, underwent CRT. At thirteen months follow up, all clinical and echocardiographic parameters significantly improves (EF p or = 5 units. There was a significant difference of LVED diameter (p<0.05) and HRV (p<0.05) between responders and non responders. Receiver-operating curve analysis showed that a positive response to CRT may be predicted in patients with LVED diameter <67 mm (with a sensitivity of 77% and a specificity of 88%). Our results confirm the clinical improvement obtained by CRT in end-stage heart failure patients as well as the limited value of QRS duration and intraventricular dyssynchrony as predictor of clinical recovery after CRT. While a most-advanced clinical stage of disease (HRV) without an advance left ventricular remodeling (LVED diameter) demonstrated to predict response to CRT, with sensitivity of 77% and specificity of 88%.
- 1 December 2006
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 7
Contrast echocardiography: the role of sulfur hexafluoride in achieving optimal results
Recent advances in contrast echocardiography have improved the non-invasive assessment of cardiac structure and function. The use of harmonic imaging in combination with ultrasonic contrast agents such as SonoVue® provides diagnostic information that was previously difficult or impossible to obtain by standard two-dimensional echocardiography. A large number of studies have shown the advantages of using an ultrasonic contrast agent during stress echocardiography and for myocardial perfusion imaging. We will review the main advantages of using ultrasonic contrast agents during echocardiographic examination.
- 1 December 2006
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 7
Contrast echocardiography: the role of sulfur hexafluoride in achieving optimal results
Recent advances in contrast echocardiography have improved the non-invasive assessment of cardiac structure and function. The use of harmonic imaging in combination with ultrasonic contrast agents such as SonoVue® provides diagnostic information that was previously difficult or impossible to obtain by standard two-dimensional echocardiography. A large number of studies have shown the advantages of using an ultrasonic contrast agent during stress echocardiography and for myocardial perfusion imaging. We will review the main advantages of using ultrasonic contrast agents during echocardiographic examination.